Gen Re

Lesen Sie unseren neuen Blog über die Abnehmspritze: https://lnkd.in/ea9_fqdP Das Versprechen der neuen Abnehmspritze klingt verlockend: einmal w?chentlich den Wirkstoff Semaglutid injizieren und den Pfunden beim Purzeln zusehen. Geh?ren damit übersterblichkeit und Morbidit?t aufgrund Adipositas nun der Vergangenheit an? Nach einer kurzen übersicht über das Erkrankungsbild Adipositas beleuchtet der Artikel bisherige Anwendungsgebiete und die Funktionsweise der Abnehmspritze. Auf Grundlage bisheriger Studienergebnisse stellt Dr. Katharina Dorn das Potenzial des Wirkstoffes den Risiken und Nebenwirkungen gegenüber. #insuranceresearch #healthinsurance?

New article on #wearables and #insurtechs: https://lnkd.in/edMDsA8c Insurtechs offer innovative solutions for insurers to use wearable data that provides deeper insights into customer behavior and enables personalized offers. By working with these tech start-ups, insurers can improve customer loyalty, promote a healthier lifestyle, and develop new value-added services for their customers that go beyond traditional insurance coverage. In this article, Pinar Darici, Business Analyst Digital Solutions and Tim Eppert, Head of Products & Analytics L&H Germany, describe the potential of wearables and the collaboration with insurtech companies for the insurance industry. #insuranceresearch

Insurance fraud is a global threat for all lines of business - costing the industry billions of dollars per year. Gen Re’s recent Insurance Claims Fraud Surveys obtained data from dozens of companies that offer a variety of Life, Health, and Disability products – in the U.S., Canada, UK & Ireland, and South Africa. Our latest from Mary Enslin, Life/Health Segment Claims Manager, shares the Canada survey result highlights just released today.? See all the survey highlights: https://lnkd.in/esK_yuDE Companies are leveraging many of the industry-recognized best practices that are known to effectively mitigate risk, but opportunities remain. Here’s a few top takeaways. #fraudprevention #insurancefraud #internationalfraudawarenessweek #FraudWeek

New blog: "The Risk and Challenges of Foreign Death Investigations" https://lnkd.in/e5qCaxRe There are many risks and challenges associated with foreign death investigations. Highlighting the reminder during this #InternationalFraudAwarenessWeek (November 17-23), Life Claims professionals should read our latest blog outlining the risks and challenges to consider in your claims processes. Clients can reach out to Jason Weesner, CFE, CIFI, FCLS, Head of Global Special Investigations (Forensics), to discuss how Gen Re can help. #fraudprevention #insurancefraud #FraudWeek

Today begins #InternationalFraudAwarenessWeek (Nov. 17-23) – sponsored by the Association of Certified Fraud Examiners (ACFE). #InsuranceFraud is a serious problem that affects all lines of insurance, both companies and their policyholders. In the U.S. alone, insurance fraud across all product lines is estimated to cost the industry approximately $308.6 billion per year. Gen Re is committed to fraud risk management, including sharing awareness and training – a crucial part of any fraud risk mitigation strategy. See how our Life & Health staff has connected with clients on this topic this year. For more discussions, clients can contact Jason Weesner, CFE, CIFI, FCLS, Head of Global Special Investigations (Forensics). P&C clients can contact Glenn Frankel of North America P&C Claims or Edmund Fernandez, Head of International P&C Claims. #fraudprevention #FraudWeek

In this recent interview with Richard Banks from AM Best TV, Gen Re Chief Technology Officer Frank A. Schmid talks about the #AI journey and the appetite of insurance companies to embrace the full opportunities new general-purpose technologies will bring. “One does not have to spend a lot of money on it. I think it’s more important to be smart…It’s a multi-decade process.” https://lnkd.in/e7jDdBGd Read more in Frank’s blogs: https://lnkd.in/e-vUm_M4 #GPT #artificialintelligence #insuranceinnovation

YOU ARE INVITED: WEDNESDAY, NOVEMBER 20, 12:00p.m.-1:00p.m.(EDT) Join our webinar for Life & Health professionals: "Economic and Capital Market Outlook". Speaker: Jennifer Quisenberry, CFA, Chief Investment Officer, New England Asset Management, Inc. (NEAM, Inc.). This session will discuss the U.S. economy and the likely impact of the Presidential election on issues such as inflation, employment, corporate revenues, and potential GDP growth. In addition, Jennifer will look at the recent actions of the Federal Open Market Committee (FOMC) and how those will impact interest rates, yield curves, and capital markets as we head into 2025. If you're not already signed up to receive the links to Gen Re's Life & Health North America Open Webinars, register here: https://lnkd.in/eSq7TmVA #KnowledgeSharing

Gen Re is a proud sponsor of the 6th Global Insurance Fraud Summit (being held in Singapore 11-13 Nov.). Jason Weesner, CFE, CIFI, FCLS, Head of Global Special Investigations (Forensics), is a presenter and member of the Organizing Committee. Jason will moderate a segment called “Empowering Excellence:?Industry Training and Education” and he'll present on "Life & Health Global Fraud Trends, and the Frameworks for Effective Fraud Mitigation”. With him in attendance will be Edmund Fernandez, Head of International P&C Claims. #KnowledgeSharing #InsuranceFraud #GlobalInsuranceFraudSummit #ProudSponsor

New blog: "Phthalates - Why Now and Should We Be Worried?"? https://lnkd.in/exGkQ_ec Phthalates are widely used in consumer products, including healthcare products – and so, an emerging health concern. Our blog from Claims Executives Allison Harmony and Kent Willis review the current regulations, recent litigation, and potential insurance implications with the evolving risks associated with phthalates exposure claims. #GeneralLiability #CommercialLines #CommercialUmbrella?

Read our new blog: "Alzheimer’s Disease Overview – Detection and New Treatments" https://lnkd.in/eWZmar_G New anti-amyloid antibody treatments show promise in slowing Alzheimer’s progression in early stages. Challenges include identifying suitable patients, managing side effects, and navigating coverage. Cecil Ramotar, Sr. Underwriting Executive, provides a comprehensive overview of the disease and emerging treatment’s potential impact. #alzheimers #alzheimersawareness #dementiaawareness #LifeInsurance #InsuranceClaims